Krishnaswamy Yeleswaram,Bhavnish Parikh,Dilip P. Modi,Trupti Sheth
申请号：
US15599084
公开号：
US20170319487A1
申请日:
2017.05.18
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto.
